STOCK TITAN

Omnicell Inc - $OMCL STOCK NEWS

Welcome to our dedicated page for Omnicell news (Ticker: $OMCL), a resource for investors and traders seeking the latest updates and insights on Omnicell stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Omnicell's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Omnicell's position in the market.

Rhea-AI Summary
Omnicell, Inc. will release its financial results for the third quarter of 2023 on November 2nd. A conference call and webcast will be held to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
-
Rhea-AI Summary
Omnicell, Inc. to present at 2023 Wells Fargo Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.55%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.67%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.52%
Tags
none
-
Rhea-AI Summary
Omnicell announces the appointment of Nchacha E. Etta as Executive Vice President and Chief Financial Officer, effective June 1, 2023. Mr. Etta brings over 20 years of finance and accounting experience to the company, having previously served in leadership roles at Essilor of America, Johnson & Johnson Vision, The Coca-Cola Company, Microsoft Corporation, and Eli Lilly and Company. Omnicell expects to benefit from Mr. Etta's expertise in finance and accounting, as well as his broader leadership experience, as they continue to focus on their recent acquisitions and operational efficiencies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.26%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.54%
Tags
conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.51%
Tags
none
Omnicell Inc

Nasdaq:OMCL

OMCL Rankings

OMCL Stock Data

1.38B
45.23M
1.47%
101.18%
5.06%
Electronic Computer Manufacturing
Manufacturing
Link
United States of America
FORT WORTH

About OMCL

since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice